Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

SKIN REPLACEMENT TESTS SHOW PROMISE

Oct. 22, 1991

HUMAN TESTS OF BIOCINE'S AIDS VACCINE

Oct. 22, 1991

FACTOR VIII MAb HELPS SUPPRESS AIDS

Oct. 22, 1991

ANTISENSE RNA STOPS RIPENING

Oct. 22, 1991

IDEXX BUYS DIAGNOSTICS BUSINESS

Oct. 22, 1991

PATENT TRIAL RESCHEDULED

Oct. 22, 1991

KININ BLOCKERS vs. SEPTIC SHOCK

Oct. 22, 1991

ONCOTECH CUTS PRICES ON CANCER TESTS

Oct. 22, 1991

ISIS LICENSES ANTISENSE HERPES DRUG

Oct. 21, 1991

PROMISING HIV ANTI-INFECTIVE

Oct. 21, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...